Shareholders of GlaxoSmithKline Consumer Nigeria Plc will on December 8, 2022, at an extraordinary general meeting vote on a special resolution to approve the cancellation of 304,123,512 unissued ordinary shares of 50 kobo each which comprise the total number of unissued shares in the share capital of the company.

This, the company said in a notification to the Nigerian Exchange Limited by Frederick Ichekwai, the Company Secretary, is “in compliance with Section 124 of the Companies and Allied Matters Act No 3 of 2020 (as amended) and Regulation 13 of the Companies Regulation 2021, shareholders hereby authorize.”